Blar i forfatter "Evjen, Tove Julie"

Viser treff 1-4 av 4

    • Development of improved bendamustin-liposomes 

      Evjen, Tove Julie (Master thesis; Mastergradsoppgave, 2007-05)
      Bendamustin is an alkylating anticancer agent which is currently in routine use for the treatment of different types of cancer. The drug is very unstable in serum due to hydrolysis; the half life of the first part of the serum elimination curve is about 6-10 minutes. The rapid degradation of the drug in serum impairs its cytostatic action within a short period of time, and frequent application of ...

    • Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin 

      Evjen, Tove Julie; Brandl, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
      Ultrasound sensitive (sonosensitive liposomes) are drug delivery systems designed for releasing their drug load upon exposure to ultrasound (US). Inclusion of dioleoylphosphatidylethanolamine (DOPE) in liposome membranes was previously shown to induce sonosensitivity. For efficient US mediated drug delivery to solid tumours, a long blood circulation time of the liposomal drug providing high tumour ...

    • Sonosensitive liposomes for ultrasound-mediated drug delivery 

      Evjen, Tove Julie (Doctoral thesis; Doktorgradsavhandling, 2011-06-20)
      Liposome encapsulation of cytotoxic drugs favours drug delivery to tumours and improves the therapeutic-to-toxicity ratio of conventional chemotherapy. A novel approach to further enhance the availability of liposomal drugs to tumour cells is to combine ultrasound (US) with US sensitive (sonosensitive) liposomes. US treatment of tumour tissue induces local drug release from the liposome carrier ...

    • Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine 

      Evjen, Tove Julie; Nilssen, Esben A.; Barnert, Sabine; Schubert, Rolf; Brandl, Martin; Fossheim, Sigrid L (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
      Novel sonosensitive doxorubicin-containing liposomes comprising dioleoylphosphatidylethanolamine (DOPE) as the main lipid constituent were developed and characterized in terms of ultrasound-mediated drug release in vitro. The liposome formulation showed high sonosensitivity; where approximately 95% doxorubicin was released from liposomes after 6 min of 40 kHz US exposure in buffered sucrose solution. ...